Astaxanthin Protects Ochratoxin A-Induced Oxidative Stress and Apoptosis in the Heart via the Nrf2 Pathway

Gengyuan Cui1, Lin Li1,2, Weixiang Xu1

  • 1Key Laboratory of Zoonosis of Liaoning Province, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.

Insights

Astaxanthin (ASX) protects against ochratoxin A (OTA)-induced cardiac injury by modulating oxidative stress and apoptosis. ASX treatment improved cardiac function and antioxidant levels, demonstrating its cardioprotective effects against OTA toxicity.

Area of Science:

  • Toxicology
  • Cardiovascular Biology
  • Nutraceutical Research

Background:

  • Ochratoxin A (OTA) is a nephrotoxic and carcinogenic mycotoxin that can cause cardiac injury.
  • Astaxanthin (ASX) is a potent antioxidant carotenoid with potential therapeutic benefits.

Purpose of the Study:

  • To investigate the protective mechanism of astaxanthin (ASX) against ochratoxin A (OTA)-induced cardiac injury in mice.
  • To elucidate the molecular pathways involved in OTA-induced myocardial damage and ASX's protective effects.

Main Methods:

  • Mice were divided into control, OTA, ASX, and ASX + OTA groups.
  • Evaluated cardiac function via electrocardiogram, body/heart weight, and tissue pathology.
  • Assessed oxidative stress markers (MDA, SOD, CAT, GSH), cardiac enzymes (CK, CK-MB, LDH), and apoptosis (TUNEL assay).
  • Utilized electron microscopy and Western blot to analyze protein expression related to the Keap1-Nrf2 and apoptosis pathways.

Main Results:

  • OTA exposure significantly impaired cardiac function, reduced body and heart weight, and induced oxidative stress and apoptosis.
  • ASX administration ameliorated OTA-induced cardiac injury, improving heart rate, antioxidant status, and reducing cardiac enzyme levels.
  • ASX treatment reversed OTA-induced changes in protein expression, including the Keap1-Nrf2 pathway and apoptosis-related proteins (Bax, Bcl-2, Caspase3, Caspase9).

Conclusions:

  • Astaxanthin exerts significant cardioprotective effects against ochratoxin A-induced myocardial injury.
  • The protective mechanism involves the modulation of the Keap1-Nrf2 signaling pathway and inhibition of mitochondria-mediated apoptosis.
  • These findings highlight the therapeutic potential of astaxanthin in mitigating mycotoxin-induced cardiac damage.

Related Concept Videos

Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K